APO Research
Talk to an analyst

APO RESEARCH · REPORT

Dalbavancin

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Dalbavancin Industry Growth and Trends Forecast to 2032

22 December 2025101 pages

Choose your research edition.

Industry ResearchDalbavancin Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Dalbavancin Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Dalbavancin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dalbavancin Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Dalbavancin Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Dalbavancin market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Dalbavancin is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Dalbavancin is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Dalbavancin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Dalbavancin include Sanofi, Novartis, Merck, Roche, Pfizer, GSK, Amgen, Abbvie and Johnson, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Dalbavancin market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Dalbavancin market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Dalbavancin market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Dalbavancin.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Dalbavancin market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Dalbavancin Market by Company

Sanofi

Novartis

Merck

Roche

Pfizer

GSK

Amgen

Abbvie

Johnson

Hayao

Gilead

Dalbavancin Segment by Type

Intravenous Therapy

Oral Type

Dalbavancin Segment by Application

Skin Infection

Soft Tissue Infection

Others

Dalbavancin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dalbavancin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dalbavancin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dalbavancin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Dalbavancin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Dalbavancin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Intravenous Therapy Table 2. Major Company of Oral Type Table 3. Global Dalbavancin Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Dalbavancin Sales by Type (2021-2026) & (k units) Table 5. Global Dalbavancin Sales Market Share in Volume by Type (2021-2026) Table 6. Global Dalbavancin Sales by Type (2021-2026) & (US$ Million) Table 7. Global Dalbavancin Sales Market Share in Value by Type (2021-2026) Table 8. Global Dalbavancin Price by Type (2021-2026) & (US$/unit) Table 9. Global Dalbavancin Sales by Type (2027-2032) & (k units) Table 10. Global Dalbavancin Sales Market Share in Volume by Type (2027-2032) Table 11. Global Dalbavancin Sales by Type (2027-2032) & (US$ Million) Table 12. Global Dalbavancin Sales Market Share in Value by Type (2027-2032) Table 13. Global Dalbavancin Price by Type (2027-2032) & (US$/unit) Table 14. North America Dalbavancin Sales by Type (2021-2026) & (k units) Table 15. North America Dalbavancin Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Dalbavancin Sales by Type (2021-2026) & (k units) Table 17. Europe Dalbavancin Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Dalbavancin Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Dalbavancin Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Dalbavancin Sales by Type (2021-2026) & (k units) Table 21. Latin America Dalbavancin Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Dalbavancin Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Dalbavancin Sales by Type (2021-2026) & (US$ Million) Table 24. Dalbavancin Industry Trends Table 25. Dalbavancin Industry Drivers Table 26. Dalbavancin Industry Opportunities and Challenges Table 27. Dalbavancin Industry Restraints Table 28. Global Dalbavancin Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Dalbavancin Revenue Market Share by Company (2021-2026) Table 30. Global Dalbavancin Sales by Company (2021-2026) & (k units) Table 31. Global Dalbavancin Sales Share by Company (2021-2026) Table 32. Global Dalbavancin Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Dalbavancin Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Dalbavancin Major Company Production Sites and Headquarters Table 35. Global Dalbavancin Company, Product Type & Application Table 36. Global Dalbavancin Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Dalbavancin by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Dalbavancin Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Dalbavancin Sales by Region (2021-2026) & (k units) Table 41. Global Dalbavancin Sales Market Share in Volume by Region (2021-2026) Table 42. Global Dalbavancin Sales by Region (2021-2026) & (US$ Million) Table 43. Global Dalbavancin Sales Market Share in Value by Region (2021-2026) Table 44. Global Dalbavancin Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Dalbavancin Sales by Region (2027-2032) & (k units) Table 46. Global Dalbavancin Sales Market Share in Volume by Region (2027-2032) Table 47. Global Dalbavancin Sales by Region (2027-2032) & (US$ Million) Table 48. Global Dalbavancin Sales Market Share in Value by Region (2027-2032) Table 49. Global Dalbavancin Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Dalbavancin Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Dalbavancin Sales by Application (2021-2026) & (k units) Table 52. Global Dalbavancin Sales Market Share in Volume by Application (2021-2026) Table 53. Global Dalbavancin Sales by Application (2021-2026) & (US$ Million) Table 54. Global Dalbavancin Sales Market Share in Value by Application (2021-2026) Table 55. Global Dalbavancin Price by Application (2021-2026) & (US$/unit) Table 56. Global Dalbavancin Sales by Application (2027-2032) & (k units) Table 57. Global Dalbavancin Sales Market Share in Volume by Application (2027-2032) Table 58. Global Dalbavancin Sales by Application (2027-2032) & (US$ Million) Table 59. Global Dalbavancin Sales Market Share in Value by Application (2027-2032) Table 60. Global Dalbavancin Price by Application (2027-2032) & (US$/unit) Table 61. North America Dalbavancin Sales by Application (2021-2026) & (k units) Table 62. North America Dalbavancin Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Dalbavancin Sales by Application (2021-2026) & (k units) Table 64. Europe Dalbavancin Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Dalbavancin Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Dalbavancin Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Dalbavancin Sales by Application (2021-2026) & (k units) Table 68. Latin America Dalbavancin Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Dalbavancin Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Dalbavancin Sales by Application (2021-2026) & (US$ Million) Table 71. Sanofi Company Information Table 72. Sanofi Business Overview Table 73. Sanofi Dalbavancin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Sanofi Dalbavancin Product Portfolio Table 75. Sanofi Recent Development Table 76. Novartis Company Information Table 77. Novartis Business Overview Table 78. Novartis Dalbavancin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Novartis Dalbavancin Product Portfolio Table 80. Novartis Recent Development Table 81. Merck Company Information Table 82. Merck Business Overview Table 83. Merck Dalbavancin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Merck Dalbavancin Product Portfolio Table 85. Merck Recent Development Table 86. Roche Company Information Table 87. Roche Business Overview Table 88. Roche Dalbavancin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Roche Dalbavancin Product Portfolio Table 90. Roche Recent Development Table 91. Pfizer Company Information Table 92. Pfizer Business Overview Table 93. Pfizer Dalbavancin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Pfizer Dalbavancin Product Portfolio Table 95. Pfizer Recent Development Table 96. GSK Company Information Table 97. GSK Business Overview Table 98. GSK Dalbavancin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. GSK Dalbavancin Product Portfolio Table 100. GSK Recent Development Table 101. Amgen Company Information Table 102. Amgen Business Overview Table 103. Amgen Dalbavancin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Amgen Dalbavancin Product Portfolio Table 105. Amgen Recent Development Table 106. Abbvie Company Information Table 107. Abbvie Business Overview Table 108. Abbvie Dalbavancin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. Abbvie Dalbavancin Product Portfolio Table 110. Abbvie Recent Development Table 111. Johnson Company Information Table 112. Johnson Business Overview Table 113. Johnson Dalbavancin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. Johnson Dalbavancin Product Portfolio Table 115. Johnson Recent Development Table 116. Hayao Company Information Table 117. Hayao Business Overview Table 118. Hayao Dalbavancin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 119. Hayao Dalbavancin Product Portfolio Table 120. Hayao Recent Development Table 121. Gilead Company Information Table 122. Gilead Business Overview Table 123. Gilead Dalbavancin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 124. Gilead Dalbavancin Product Portfolio Table 125. Gilead Recent Development Table 126. North America Dalbavancin Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 127. North America Dalbavancin Sales by Country (2021-2026) & (k units) Table 128. North America Dalbavancin Sales Market Share by Country (2021-2026) Table 129. North America Dalbavancin Sales Forecast by Country (2027-2032) & (k units) Table 130. North America Dalbavancin Sales Market Share Forecast by Country (2027-2032) Table 131. North America Dalbavancin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. North America Dalbavancin Market Size by Country (2021-2026) & (US$ Million) Table 133. North America Dalbavancin Market Share by Country (2021-2026) Table 134. North America Dalbavancin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. North America Dalbavancin Market Share Forecast by Country (2027-2032) Table 136. Europe Dalbavancin Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 137. Europe Dalbavancin Sales by Country (2021-2026) & (k units) Table 138. Europe Dalbavancin Sales Market Share by Country (2021-2026) Table 139. Europe Dalbavancin Sales Forecast by Country (2027-2032) & (k units) Table 140. Europe Dalbavancin Sales Market Share Forecast by Country (2027-2032) Table 141. Europe Dalbavancin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Europe Dalbavancin Market Size by Country (2021-2026) & (US$ Million) Table 143. Europe Dalbavancin Market Share by Country (2021-2026) Table 144. Europe Dalbavancin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Europe Dalbavancin Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific Dalbavancin Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific Dalbavancin Sales by Country (2021-2026) & (k units) Table 148. Asia-Pacific Dalbavancin Sales Market Share by Country (2021-2026) Table 149. Asia-Pacific Dalbavancin Sales Forecast by Country (2027-2032) & (k units) Table 150. Asia-Pacific Dalbavancin Sales Market Share Forecast by Country (2027-2032) Table 151. Asia-Pacific Dalbavancin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Asia-Pacific Dalbavancin Market Size by Country (2021-2026) & (US$ Million) Table 153. Asia-Pacific Dalbavancin Market Share by Country (2021-2026) Table 154. Asia-Pacific Dalbavancin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Asia-Pacific Dalbavancin Market Share Forecast by Country (2027-2032) Table 156. Latin America Dalbavancin Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 157. Latin America Dalbavancin Sales by Country (2021-2026) & (k units) Table 158. Latin America Dalbavancin Sales Market Share by Country (2021-2026) Table 159. Latin America Dalbavancin Sales Forecast by Country (2027-2032) & (k units) Table 160. Latin America Dalbavancin Sales Market Share Forecast by Country (2027-2032) Table 161. Latin America Dalbavancin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Latin America Dalbavancin Market Size by Country (2021-2026) & (US$ Million) Table 163. Latin America Dalbavancin Market Share by Country (2021-2026) Table 164. Latin America Dalbavancin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Latin America Dalbavancin Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa Dalbavancin Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa Dalbavancin Sales by Country (2021-2026) & (k units) Table 168. Middle East and Africa Dalbavancin Sales Market Share by Country (2021-2026) Table 169. Middle East and Africa Dalbavancin Sales Forecast by Country (2027-2032) & (k units) Table 170. Middle East and Africa Dalbavancin Sales Market Share Forecast by Country (2027-2032) Table 171. Middle East and Africa Dalbavancin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Middle East and Africa Dalbavancin Market Size by Country (2021-2026) & (US$ Million) Table 173. Middle East and Africa Dalbavancin Market Share by Country (2021-2026) Table 174. Middle East and Africa Dalbavancin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Middle East and Africa Dalbavancin Market Share Forecast by Country (2027-2032) Table 176. Key Raw Materials Table 177. Raw Materials Key Suppliers Table 178. Dalbavancin Distributors List Table 179. Dalbavancin Customers List Table 180. Research Programs/Design for This Report Table 181. Authors List of This Report Table 182. Secondary Sources Table 183. Primary Sources List of Figures Figure 1. Dalbavancin Image Figure 2. Global Dalbavancin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Dalbavancin Market Size (2021-2032) & (US$ Million) Figure 4. Global Dalbavancin Sales (2021-2032) & (k units) Figure 5. Intravenous Therapy Image Figure 6. Global Intravenous Therapy Sales YoY Growth (2021-2032) & (k units) Figure 7. Oral Type Image Figure 8. Global Oral Type Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Dalbavancin Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Dalbavancin Market Share by Type 2025 VS 2032 Figure 11. North America Dalbavancin Sales Market Share in Volume by Type in 2025 Figure 12. North America Dalbavancin Sales Market Share in Value by Type in 2025 Figure 13. Europe Dalbavancin Sales Market Share in Volume by Type in 2025 Figure 14. Europe Dalbavancin Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Dalbavancin Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Dalbavancin Sales Market Share in Value by Type in 2025 Figure 17. Latin America Dalbavancin Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Dalbavancin Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Dalbavancin Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Dalbavancin Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Dalbavancin Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Skin Infection Image Figure 24. Global Skin Infection Sales YoY Growth (2021-2032) & (k units) Figure 25. Soft Tissue Infection Image Figure 26. Global Soft Tissue Infection Sales YoY Growth (2021-2032) & (k units) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 29. Global Dalbavancin Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Dalbavancin Market Share by Application 2025 VS 2032 Figure 31. North America Dalbavancin Sales Market Share in Volume by Application in 2025 Figure 32. North America Dalbavancin Sales Market Share in Value by Application in 2025 Figure 33. Europe Dalbavancin Sales Market Share in Volume by Application in 2025 Figure 34. Europe Dalbavancin Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Dalbavancin Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Dalbavancin Sales Market Share in Value by Application in 2025 Figure 37. Latin America Dalbavancin Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Dalbavancin Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Dalbavancin Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Dalbavancin Sales Market Share in Value by Application in 2025 Figure 41. North America Dalbavancin Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 42. North America Dalbavancin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Dalbavancin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Dalbavancin Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Dalbavancin Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. Europe Dalbavancin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Dalbavancin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Dalbavancin Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Dalbavancin Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Asia-Pacific Dalbavancin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Dalbavancin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Dalbavancin Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Dalbavancin Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Latin America Dalbavancin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Dalbavancin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Dalbavancin Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Dalbavancin Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Middle East and Africa Dalbavancin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Dalbavancin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Dalbavancin Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Dalbavancin Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Dalbavancin Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Intravenous Therapy
  • Oral Type
Applications
  • Skin Infection
  • Soft Tissue Infection
  • Others
Companies covered
  • Sanofi
  • Novartis
  • Merck
  • Roche
  • Pfizer
  • GSK
  • Amgen
  • Abbvie
  • Johnson
  • Hayao
  • Gilead

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Dalbavancin Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Dalbavancin Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Dalbavancin Market by Type
  6. 1.3.1 Intravenous Therapy
  7. 1.3.2 Oral Type
  8. 1.4 Global Dalbavancin Market Size by Type
  9. 1.4.1 Global Dalbavancin Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Dalbavancin Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Dalbavancin Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Dalbavancin Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Dalbavancin Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Dalbavancin Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Dalbavancin Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Dalbavancin Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Dalbavancin Industry Trends
  2. 2.2 Dalbavancin Industry Drivers
  3. 2.3 Dalbavancin Industry Opportunities and Challenges
  4. 2.4 Dalbavancin Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Dalbavancin Revenue (2021-2026)
  2. 3.2 Global Top Players by Dalbavancin Sales (2021-2026)
  3. 3.3 Global Top Players by Dalbavancin Price (2021-2026)
  4. 3.4 Global Dalbavancin Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Dalbavancin Major Company Production Sites & Headquarters
  6. 3.6 Global Dalbavancin Company, Product Type & Application
  7. 3.7 Global Dalbavancin Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Dalbavancin Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Dalbavancin Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Dalbavancin Tier 1, Tier 2, and Tier 3
4 Dalbavancin Regional Status and Outlook
  1. 4.1 Global Dalbavancin Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Dalbavancin Historic Market Size by Region
  3. 4.2.1 Global Dalbavancin Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Dalbavancin Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Dalbavancin Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Dalbavancin Forecasted Market Size by Region
  7. 4.3.1 Global Dalbavancin Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Dalbavancin Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Dalbavancin Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Dalbavancin by Application
  1. 5.1 Dalbavancin Market by Application
  2. 5.1.1 Skin Infection
  3. 5.1.2 Soft Tissue Infection
  4. 5.1.3 Others
  5. 5.2 Global Dalbavancin Market Size by Application
  6. 5.2.1 Global Dalbavancin Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Dalbavancin Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Dalbavancin Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Dalbavancin Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Dalbavancin Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Dalbavancin Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Dalbavancin Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Dalbavancin Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Sanofi
  2. 6.1.1 Sanofi Company Information
  3. 6.1.2 Sanofi Business Overview
  4. 6.1.3 Sanofi Dalbavancin Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Sanofi Dalbavancin Product Portfolio
  6. 6.1.5 Sanofi Recent Developments
  7. 6.2 Novartis
  8. 6.2.1 Novartis Company Information
  9. 6.2.2 Novartis Business Overview
  10. 6.2.3 Novartis Dalbavancin Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Novartis Dalbavancin Product Portfolio
  12. 6.2.5 Novartis Recent Developments
  13. 6.3 Merck
  14. 6.3.1 Merck Company Information
  15. 6.3.2 Merck Business Overview
  16. 6.3.3 Merck Dalbavancin Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Merck Dalbavancin Product Portfolio
  18. 6.3.5 Merck Recent Developments
  19. 6.4 Roche
  20. 6.4.1 Roche Company Information
  21. 6.4.2 Roche Business Overview
  22. 6.4.3 Roche Dalbavancin Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Roche Dalbavancin Product Portfolio
  24. 6.4.5 Roche Recent Developments
  25. 6.5 Pfizer
  26. 6.5.1 Pfizer Company Information
  27. 6.5.2 Pfizer Business Overview
  28. 6.5.3 Pfizer Dalbavancin Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Pfizer Dalbavancin Product Portfolio
  30. 6.5.5 Pfizer Recent Developments
  31. 6.6 GSK
  32. 6.6.1 GSK Company Information
  33. 6.6.2 GSK Business Overview
  34. 6.6.3 GSK Dalbavancin Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 GSK Dalbavancin Product Portfolio
  36. 6.6.5 GSK Recent Developments
  37. 6.7 Amgen
  38. 6.7.1 Amgen Company Information
  39. 6.7.2 Amgen Business Overview
  40. 6.7.3 Amgen Dalbavancin Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Amgen Dalbavancin Product Portfolio
  42. 6.7.5 Amgen Recent Developments
  43. 6.8 Abbvie
  44. 6.8.1 Abbvie Company Information
  45. 6.8.2 Abbvie Business Overview
  46. 6.8.3 Abbvie Dalbavancin Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Abbvie Dalbavancin Product Portfolio
  48. 6.8.5 Abbvie Recent Developments
  49. 6.9 Johnson
  50. 6.9.1 Johnson Company Information
  51. 6.9.2 Johnson Business Overview
  52. 6.9.3 Johnson Dalbavancin Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Johnson Dalbavancin Product Portfolio
  54. 6.9.5 Johnson Recent Developments
  55. 6.10 Hayao
  56. 6.10.1 Hayao Company Information
  57. 6.10.2 Hayao Business Overview
  58. 6.10.3 Hayao Dalbavancin Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Hayao Dalbavancin Product Portfolio
  60. 6.10.5 Hayao Recent Developments
  61. 6.11 Gilead
  62. 6.11.1 Gilead Company Information
  63. 6.11.2 Gilead Business Overview
  64. 6.11.3 Gilead Dalbavancin Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Gilead Dalbavancin Product Portfolio
  66. 6.11.5 Gilead Recent Developments
7 North America by Country
  1. 7.1 North America Dalbavancin Sales by Country
  2. 7.1.1 North America Dalbavancin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Dalbavancin Sales by Country (2021-2026)
  4. 7.1.3 North America Dalbavancin Sales Forecast by Country (2027-2032)
  5. 7.2 North America Dalbavancin Market Size by Country
  6. 7.2.1 North America Dalbavancin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Dalbavancin Market Size by Country (2021-2026)
  8. 7.2.3 North America Dalbavancin Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Dalbavancin Sales by Country
  2. 8.1.1 Europe Dalbavancin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Dalbavancin Sales by Country (2021-2026)
  4. 8.1.3 Europe Dalbavancin Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Dalbavancin Market Size by Country
  6. 8.2.1 Europe Dalbavancin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Dalbavancin Market Size by Country (2021-2026)
  8. 8.2.3 Europe Dalbavancin Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Dalbavancin Sales by Country
  2. 9.1.1 Asia-Pacific Dalbavancin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Dalbavancin Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Dalbavancin Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Dalbavancin Market Size by Country
  6. 9.2.1 Asia-Pacific Dalbavancin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Dalbavancin Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Dalbavancin Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Dalbavancin Sales by Country
  2. 10.1.1 South America Dalbavancin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Dalbavancin Sales by Country (2021-2026)
  4. 10.1.3 South America Dalbavancin Sales Forecast by Country (2027-2032)
  5. 10.2 South America Dalbavancin Market Size by Country
  6. 10.2.1 South America Dalbavancin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Dalbavancin Market Size by Country (2021-2026)
  8. 10.2.3 South America Dalbavancin Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Dalbavancin Sales by Country
  2. 11.1.1 Middle East and Africa Dalbavancin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Dalbavancin Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Dalbavancin Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Dalbavancin Market Size by Country
  6. 11.2.1 Middle East and Africa Dalbavancin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Dalbavancin Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Dalbavancin Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Dalbavancin Value Chain Analysis
  2. 12.1.1 Dalbavancin Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Dalbavancin Production Mode & Process
  7. 12.2 Dalbavancin Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Dalbavancin Distributors
  10. 12.2.3 Dalbavancin Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst